Medical use of tafoxiparin
AssigneeDilafor AB
InventorsLena Degling-Wikingsson, Gunvor Ekman-Ordeberg
Life of this patent
Estimating the term…
Abstract
The present invention is directed to tafoxiparin for use in the spontaneous onset of labor in a term pregnant woman, wherein tafoxiparin is administered in a daily dose of 30-320 mg per day.
Claims30
A method for the spontaneous onset of labor in a term pregnant woman in need thereof, the method comprising administering a therapeutically effective amount of tafoxiparin in a daily dose of 150 to 320 mg per day, as a monotherapy, to said term pregnant woman.
A method for the spontaneous onset of labor in a term pregnant woman in need thereof having an unripe cervix, the method comprising administering a therapeutically effective amount of tafoxiparin in a daily dose of 150-320 mg, as a monotherapy, to said term pregnant woman.
A method for cervical ripening in a term pregnant woman in need thereof having an unripe cervix, the method comprising administering a therapeutically effective amount of tafoxiparin in a daily dose of 150-320 mg, as a monotherapy, to said term pregnant woman.
A method for priming of labor to obtain spontaneous onset of labor in a term pregnant woman in need thereof, the method comprising administering a therapeutically effective amount of tafoxiparin in a daily dose of 150 to 320 mg per day, as a monotherapy, to said term pregnant woman.
Dependencies are inferred from the claim text.